leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 22:39:17 - browse：3714

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Close Medicare's dangerous gaps in addiction treatment coverage

entertainment

WSS

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Aspartame and sugar

Montana youths win climate lawsuit against state for promoting fossil fuels

Novo Nordisk touts Wegovy study, but still struggling with supply

Mark Cuban is blaming the wrong people for high drug costs

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

explore

leisure time

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Megan Rapinoe shares emotional post following US Women's World Cup exit

Guidelines to prevent youth baseball injuries need more muscle

Indictment alleges Trump's ex

Novavax promises a turnaround & Lilly roils the obesity market

Megan Rapinoe shares emotional post following US Women's World Cup exit

In Memoriam: Notable people who died in 2023

Maui wildfire now ranks as the fifth

In age of alternative facts, a scholarly course on calling out crap

Why rehabilitation engineers need to center patients in their research

knowledge

Orangutan used medicinal plant to treat wound, first time ever seen

Judge sides with young activists in first

Q&A: Jennifer Adair on making gene therapy available globally

Bird flu in milk supply is likely coming from asymptomatic cows

Melinda French Gates resigns from Gates Foundation

Health AI: on the border between health care and tech

entertainment

hotspot

entertainment

explore